Abstract:
Background: Antimicrobial resistance [AMR] is a growing global health crisis, with the
gut microbiome emerging as a critical reservoir for multidrug-resistant [MDR] bacteria.
Central to this issue is the gut resistome, the complete set of antimicrobial resistance
genes [ARGs] present in both pathogenic and commensal gut bacteria. These genes can
be horizontally transferred, facilitating the spread of resistance across species and
environments. Conventional antibiotics are increasingly ineffective, especially in the gut
where biofilms and complex resistance mechanisms prevail. In this context,
bacteriophages offer a promising alternative, capable of targeting bacteria with high
specificity and minimal impact on beneficial microbiota. Environmental sources like
sewage and fecal filtrates may provide phages already adapted to the gut ecosystem.
Methods: This study used a combination of culturomics, 16S rRNA gene sequencing via
Oxford Nanopore Technology, and phage activity screening to evaluate the potential of
phages sourced from sewage and fecal filtrates. Stool samples from healthy donors were
processed to isolate bacterial strains under anaerobic conditions. Sequencing was
performed to assess microbial diversity, and phage activity was screened by monitoring
bacterial growth inhibition in the presence of filtrates using a 96-well microplate reader.
Results: Of the 247 bacterial isolates screened, 83 [33.6%] exhibited a significant
decrease in optical density, indicating potential bacteriophage-induced lysis. This
included 23 isolates responsive to both filtrates, 36 to sewage only, and 24 to fecal
filtrate only. Sequencing revealed that nearly 60% of microbial sequences were
unclassified, highlighting the presence of unexplored taxa. Culturomics enabled the
growth of both common and hard-to-culture organisms, including opportunistic
pathogens relevant for phage targeting.
Conclusion: The study demonstrates that sewage and fecal filtrates contain
bacteriophages capable of lysing MDR gut bacteria under anaerobic conditions. These
findings support the potential of phage therapy as a targeted, microbiome-sparing
approach to combat AMR. The integration of culturomics and sequencing proved
essential for both bacterial host identification and phage discovery. Future research
should focus on isolating individual phages, confirming their lytic activity, and
evaluating their efficacy in clinical or in vivo settings.